Literature DB >> 630551

Central nervous system involvement by ovarian carcinoma: a complication of prolonged survivial with metastatic disease.

R J Mayer, R S Berkowitz, C T Griffiths.   

Abstract

Six patients with epithelial ovarian cancer had clinical diagnoses of central nervous system (CNS) metastases during a four-year period. A thorough review of the literature shows that involvement of the CNS by ovarian cancer is a rare phenomenon. Four of the six patients developed parenchymal brain metastases whereas carcinomatous meningitis was detected in the other two. These patients were younger and survived longer from initial diagnosis than the majority of women with ovarian cancer. Five of the six patients had previously received chemotherapy and had developed metastatic spread to extraperitoneal sites. Following extensive surgical resection, chemotherapy may provide intraperitoneal and systemic control, thereby extending survival and permitting occult CNS metastases to become apparent.

Entities:  

Mesh:

Year:  1978        PMID: 630551     DOI: 10.1002/1097-0142(197802)41:2<776::aid-cncr2820410253>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  25 in total

1.  Leptomeningeal metastasis from ovarian carcinoma successfully treated by the intraventricular administration of methotrexate.

Authors:  Yasushi Goto; Noriyuki Katsumata; Shunichi Nakai; Yuko Sasajima; Kan Yonemori; Tsutomu Kouno; Chikako Shimizu; Masashi Ando; Yasuhiro Fujiwara
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

2.  Chemotherapy administered in conjunction with osmotic blood-brain barrier modification in patients with brain metastases.

Authors:  E A Neuwelt; S A Dahlborg
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

Review 3.  Leptomeningeal carcinomatosis from ovarian cancer.

Authors:  Eliza Miller; Irene Dy; Thomas Herzog
Journal:  Med Oncol       Date:  2011-10-08       Impact factor: 3.064

4.  Solitary cerebral metastasis from ovarian carcinoma: report of 4 cases.

Authors:  M Salvati; L Cervoni
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 5.  Neoplastic meningitis: diagnosis and treatment considerations.

Authors:  S M Blaney; D G Poplack
Journal:  Med Oncol       Date:  2000-08       Impact factor: 3.064

6.  Solitary cerebral metastases from ovarian epithelial carcinoma: 11 cases.

Authors:  Giancarlo D'Andrea; Raffaelino Roperto; Lavinia Dinia; Emanuela Caroli; Maurizio Salvati; Luigi Ferrante
Journal:  Neurosurg Rev       Date:  2004-11-19       Impact factor: 3.042

7.  Brain metastases from ovarian cancer.

Authors:  J Ziegler; P Gliedman; D Fass; M Beckman; A Neophytides; A Steinfeld
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

8.  Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome.

Authors:  Zvi R Cohen; Dima Suki; Jeffrey S Weinberg; Eric Marmor; Frederick F Lang; David M Gershenson; Raymond Sawaya
Journal:  J Neurooncol       Date:  2004-02       Impact factor: 4.130

9.  Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain.

Authors:  Laura M Divine; Nora T Kizer; Andrea R Hagemann; Meredith E Pittman; Ling Chen; Matthew A Powell; David G Mutch; Janet S Rader; Premal H Thaker
Journal:  Gynecol Oncol       Date:  2016-05-08       Impact factor: 5.482

10.  Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brain. A Southwest Oncology Group study.

Authors:  H J Eyre; J D Ohlsen; J Frank; A F LoBuglio; J D McCracken; T J Weatherall; C M Mansfield
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.